Tower Research Capital LLC (Trc) Penumbra Inc Transaction History

Tower Research Capital LLC (Trc)

$3.53 Billion
Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Penumbra Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 913 shares of PEN stock, worth $231,436. This represents 0.01% of its overall portfolio holdings.

Number of Shares

913

Previous 1,846 50.54%

Holding current value

$231,436

Previous $493,000 52.54%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$253.22 - $299.78 $236,254 - $279,694	-933 Reduced 50.54%	913 $234,000
Q1 2025 May 15, 2025	SELL	$237.28 - $303.76 $268,838 - $344,160	-1,133 Reduced 38.03%	1,846 $493,000
Q4 2024 Feb 13, 2025	BUY	$190.97 - $253.66 $413,450 - $549,173	2,165 Added 265.97%	2,979 $707,000
Q3 2024 Nov 14, 2024	SELL	$163.64 - $210.12 $58,746 - $75,433	-359 Reduced 30.61%	814 $158,000
Q2 2024 Aug 13, 2024	SELL	$172.27 - $223.95 $717,676 - $932,975	-4,166 Reduced 78.03%	1,173 $211,000
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $255,744 - $317,400	1,162 Added 27.82%	5,339 $1.19 Million
Q4 2023 Feb 13, 2024	BUY	$181.44 - $260.22 $86,184 - $123,604	475 Added 12.83%	4,177 $1.05 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $215,417 - $303,199	895 Added 31.88%	3,702 $895,000
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $36,657 - $46,448	135 Added 5.05%	2,807 $965,000
Q1 2023 May 09, 2023	BUY	$220.43 - $278.69 $396,553 - $501,363	1,799 Added 206.07%	2,672 $745,000
Q4 2022 Feb 10, 2023	SELL	$151.88 - $228.5 $105,860 - $159,264	-697 Reduced 44.39%	873 $194,000
Q3 2022 Nov 10, 2022	SELL	$120.36 - $205.88 $105,194 - $179,939	-874 Reduced 35.76%	1,570 $298,000
Q2 2022 Aug 15, 2022	SELL	$116.09 - $227.33 $385,534 - $754,962	-3,321 Reduced 57.61%	2,444 $305,000
Q1 2022 May 12, 2022	BUY	$187.51 - $283.98 $648,222 - $981,718	3,457 Added 149.78%	5,765 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $11,904 - $14,400	50 Added 2.21%	2,308 $663,000
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $1.65 Million - $1.92 Million	-6,599 Reduced 74.51%	2,258 $602,000
Q2 2021 Aug 16, 2021	BUY	$235.0 - $310.7 $1.1 Million - $1.45 Million	4,671 Added 111.59%	8,857 $2.43 Million
Q1 2021 May 17, 2021	SELL	$175.6 - $291.43 $889,238 - $1.48 Million	-5,064 Reduced 54.75%	4,186 $1.13 Million
Q4 2020 Feb 16, 2021	SELL	$174.98 - $272.83 $574,109 - $895,155	-3,281 Reduced 26.18%	9,250 $1.62 Million
Q3 2020 Nov 16, 2020	BUY	$185.27 - $238.73 $497,079 - $640,512	2,683 Added 27.24%	12,531 $2.44 Million
Q2 2020 Aug 13, 2020	BUY	$153.32 - $191.72 $1.5 Million - $1.87 Million	9,755 Added 10489.25%	9,848 $1.76 Million
Q1 2020 May 15, 2020	SELL	$124.34 - $193.76 $40,907 - $63,747	-329 Reduced 77.96%	93 $15,000
Q4 2019 Feb 07, 2020	BUY	$134.81 - $177.8 $23,052 - $30,403	171 Added 68.13%	422 $69,000
Q3 2019 Nov 05, 2019	SELL	$131.82 - $183.4 $105,983 - $147,453	-804 Reduced 76.21%	251 $34,000
Q2 2019 Aug 13, 2019	SELL	$124.65 - $167.39 $17,077 - $22,932	-137 Reduced 11.49%	1,055 $169,000
Q1 2019 May 14, 2019	BUY	$115.84 - $160.31 $138,081 - $191,089	1,192 New	1,192 $175,000
Q4 2018 Feb 14, 2019	SELL	$113.42 - $156.48 $37,768 - $52,107	-333 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$121.55 - $156.8 $45,702 - $58,956	-376 Reduced 53.03%	333 $50,000
Q2 2018 Aug 15, 2018	SELL	$112.2 - $165.95 $137,557 - $203,454	-1,226 Reduced 63.36%	709 $98,000
Q1 2018 May 15, 2018	BUY	$84.6 - $126.1 $121,400 - $180,953	1,435 Added 287.0%	1,935 $224,000
Q4 2017 Feb 09, 2018	SELL	$91.55 - $115.85 $160,395 - $202,969	-1,752 Reduced 77.8%	500 $47,000
Q3 2017 Nov 14, 2017	BUY	$79.65 - $90.3 $179,371 - $203,355	2,252	2,252 $203,000

Others Institutions Holding PEN

# of Institutions

506

Shares Held

30M

Call Options Held

266K

Put Options Held

59.2K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.6B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Penumbra Inc Transaction History